Bacterial overgrowth syndrome: from problem understanding to treatment
https://doi.org/10.21518/2079-701X-2017-1-198-203
Abstract
The review summarizes recent findings on the syndrome of small intestine bacterial overgrowth (SIBO) which is not a separate disease. The triggers of SIBO and the impact on gastrointestinal physiology are considered. Treatment approaches are described taking into account the mechanism of occurrence of digestive disorders. The article highlights the therapeutic effect of probiotic medicines and refers to the research profile of L. rhamnosus strain GG.
About the Author
N. I. Ursova
Moscow Regional Research and Clinical Institute named after M.F. Vladimirskiy
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
References
1. Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol, 2006, 21: 517-23.
2. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut, 2008, 57: 1605-15.
3. Faith JJ, et al. The long-term stability of the human gut microbiota. Science, 2013, 341, 1237439. doi:10.1126/science.1237439.
4. Miller LS, Vegesna AK, Sampath AM, Prabhu S, Kotapati SK, Makipour K. Ileocecal valve dis function in small intestinal bacterial overgrowth: a pilot study. WGJ, 2012, 18: 6801-6808.
5. Мартынов В.Л., Хайрдинов А.Х. Синдром избыточного бактериального роста в тонкой кишке у пациентов с недостаточностью баугиниевой заслонки и после ее хирургической коррекции (первые результаты). Бюллетень сибирской медицины, 2015, 14(2): 12-19.
6. Shelley H, Brennan M, Heuschkel R. Hydrogen breath testing in children: what is it and why is it performed? Castroint Nurs, 2009, 7: 18-27.
7. Sham HP, Yu EY, Gulen MF, Bhinder G, Stahl M, Chan JM, Brewster L, Morampudi V, Gibson DL, Hughes MR, McNagny KM, Li X, Vallance BA. SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog, 2013, 9(8): e1003539. doi: 10.1371/journal.ppat.1003539.
8. Богданова Е.А., Несвижский Ю.В., Воробьев А.А. Анализ взаимосвязи микробного состава пристеночного муцина и клинико-лабораторных показателей организма человека. Тезисы XXXII сессии Центрального научно-исследовательского института гастроэнтерологии. М., 2005: 432-433.
9. Wu C, Li Z, Xiong D. Relationship between enteric microecologic disbiosis and bacterial translocation in acute necrotizing pancreatitis. World J Gastroenterol, 1998, 4(3): 242-45.
10. Othman M., Aquero R., Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opion Gastroenterol, 2008, 24: 11-6.
11. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy, 2007, 62: 1223-36.
12. Shreiner A, Huffnagle GB, Noverr MC. The Microflora Hypothesis of allergic disease. Adv Exp Med Biol, 2008, 635: 113-34.
13. Ford AC, Spiegel BM, Talley NJ, Moaguedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol, 2009, 7: 1279-1289.
14. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenter Nutr, 2007, 44: 212-218.
15. Rubio-Tapia A, Bartom SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial over diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol, 2009, 43: 157-161.
16. Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rev, 2007, 9(2): 116-122.
17. Урсова Н.И. Синдромы нарушенного микробиоценоза у детей: причины, диагностика, терапия. Consilium Medicum. Педиатрия. 2015, 2: 58-63.
18. Белоусова Е.А. Синдром избыточного бактериального роста тонкой кишки при хроническом панкреатите. РМЖ, 2009, 17(15): 317-322.
19. Пасечников В.Д., Литвиненко И.Л. Оптимизация терапии экзокринной недостаточности поджелудочной железы посредством комбинации панкреатина в энтеросолюбильной оболочке и ингибитора протонной помпы. Клинические перспективы гастроэнтерологии, гепатологии, 2010, 2: 37-41.
20. Маев И.В., Свиридова А.В., Кучерявый Ю.А., Гончаренко А.Ю., Самсонов А.А., Оганесян Т.С., Устинова Н.Н., Казюлин А.Н., Трошина А.Н., Москалева А.Б. Длительная заместительная ферментная терапия у больных хроническим панкреатитом с экзокринной недостаточностью поджелудочной железы. Фарматека, 2011, 2: 64-71.
21. Урсова Н.И. Функциональные нарушения билиарного тракта у детей как мультидисциплинарная проблема. Альманах клинической медицины, 2014, 33: 39-48.
22. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cell and the intestinal mucus layer. Am J Clin Nutr, 2001, 73: 1131S-41S.
23. Swidsinski A, Loening-Baucke V, Verstraelen H et al. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology, 2008, 135: 568-79.
24. Clark JA, Coopersmith CM. Intestinal crosstalk – a new paradigm for understanding the gut as the «motor» of critical illness. Shock, 2007, 28(4): 384-93.
25. Урсова Н.И. Дисбактериозы кишечника в детском возрасте: инновации в диагностике, коррекции и профилактики. Руководство для врачей. М., 2013. 328 с.
26. Нетребенко О.К. Об использовании кисломолочных продуктов в питании детей первого года жизни. Некоторые забытые аспекты. Педиатрия, 2002, 6: 80-82.
27. Bruck WM, Kelleher SL, Gibson GR. rRNA probes used to quantify the effects of glycomacropeptides and a-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia Coli. J Pediatr Gastroenter and Nutr., 2003, 37: 273-280.
28. Абрамова Т.В., Георгиева О.В., Гуторова Т.В. Новый вид обогащенного биойогурта в питании детей раннего возраста. Вопросы практической педиатрии, 2011, 6(3): 1-2.
29. Thibault H, Aubert-Jacquin C, Goulet O. Effects of longterm consumption of a fermented infant formula (With Bifidobacterium breve c50 and streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr, 2004, 39: 147-52.
30. Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice – myths and realities. Aliment Pharmacol Ther, 2008, 27: 93-103.
31. Szajewska H, Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nutr, 2001, 33: S17-25.
32. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr, 2001, 73: 399S-405S.
33. Бондаренко В.М. Обоснование и тактика назначения в медицинской практике различных форм пробиотических препаратов. Фарматека, 2012, 13: 89-99.
34. Gorbach SL. Probiotics and gastrointestinal health. Am G Gastroenterol, 2000, 95(1 Suppl): 2-4S.
35. Hunter JO, Madden JA. А review of the role of the gut microflora in irritable bowel syndrome and the effect of probiotics. Br J Nutr, 2002, 88(suppl. 1): 67-72.
36. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with use of probiotics. Am J Clin Nutr, 2001, 73(2 Suppl): 430-36S.
37. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr, 2000, 130(2S Suppl): 396-402S.
38. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agent: present khuwledge and future prospects. Curr Pharm Des, 2003, 9: 175-91.
39. Timmerman HM, Koning CJM, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics. A comparison of functionality and efficacy. Int J Food Microbiol, 2004, 96: 219-33.
40. Medzhitov R. Toll-like receptors and innate immunity. Nature Reviews Immunology, 2001, 1(2): 143-45.
41. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implication for fundamental and biomedical research. Appl Envir Microbiol, 2008, 74(16): 4985-96.
42. Vinderola G, Matar C, Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol, 2005, 12(9): 1075-84.
43. Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, Bricout H, Simondon F. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of rotavirus immunization program in Finland. Pediatr Infect Dis J, 2013, 32(12): 1365-1373.
44. Quigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics, 2007, 119: 837-842.
45. Guarino A, Albano F, Ashkenazi Sh, Gendrel D, Hoekstra JH, Shamir R, Szajewska H. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroeteritis in Children in Europe. J of Pediatric Gastroenterology and Nutrition, 2008, 46: 81-184.
46. Roberfroid MB. Prebiotics: the concept revisited. J Nutr, 2007, 137(3): 830-37.
47. Roberfroid M, Robertson D. Effect of inulin and oligofructose on health and well-being. Brit J Nutr, 2005, 9(1): 1-27.
48. Horvath A, Dziechciarz P, Szayewska H. Metaanalysis: Lactobacillus rhamnosus GG in functional gastrointestinal disoders associated with abdominal pain in childhood. Alimentary Pharma cology and Therapeutics, 2013, 3: 1302- 1310.
49. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention og gastrointestinal and respiratory tract infections in children who attend care centers a randomized, double-blind, placebo controlled trial. Clin Nutr, 2010, 29(3): 312-316.
50. Kianifar H, Jafari SA, Kiani M et al. Probiotic for irritable bower syndrome in pediatrics patients a randomized controlled clinical trial. Electron Physician, 2015, 7(5): 1255-1260.
51. Derrien M, van Hylckama Vieg JET. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol, 2015, 23(6): 354-366.
52. Sanders ME. Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol, 2011, 45(3): S115-S119.
53. Martens U, Enck P, Zieseniss P. Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci, 2010, 8: 1-15.
Review
For citations:
Ursova NI. Bacterial overgrowth syndrome: from problem understanding to treatment. Meditsinskiy sovet = Medical Council. 2017;(1):198-203. (In Russ.) https://doi.org/10.21518/2079-701X-2017-1-198-203
Views:
1113
Email this article 